Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A prospective multicenter surveillance program on yeast bloodstream infections was implemented in the Paris, France, area without restrictions on ward of hospitalization (intensive care unit, hematology, and surgery) or age (adults and children). The present analysis concerns 2,618 isolates collected over 7 years from 2,441 patients. Centralized species identification and antifungal susceptibility testing using the EUCAST methodology were performed. Almost 10% (232/2,441) of the patients had recently (≤30 days) been treated with antifungal drugs. We analyzed the effect of recent exposure to fluconazole ( n = 159) or caspofungin ( n = 61) on the proportions of the five major Candida species. For both drugs, preexposure was associated with a decreased prevalence of Candida albicans in favor of less drug-susceptible species ( C. glabrata and C. krusei for the former and C. parapsilosis and, to a lesser extent, C. glabrata and C. krusei for the latter; P = 0.001). In the multivariate analysis, the risk of being infected with an isolate with decreased susceptibility to fluconazole was independently associated with an age of ≥15 years (odds ratio [OR] = 2.45; 95% confidence interval [CI] = 1.39 to 4.31; P = 0.002) and with recent exposure to fluconazole (OR = 2.17; 95% CI = 1.51 to 3.13; P < 0.001), while the risk of being infected with an isolate with decreased susceptibility to caspofungin was independently associated with an age <15 years (OR = 2.53; 95% CI = 1.43 to 4.48; P = 0.001) and with recent exposure to caspofungin (OR = 4.79; 95% CI = 2.47 to 9.28; P < 0.001). These findings could influence future recommendations for the management of candidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, Candida spp. distribution may not vary only between geographical regions, but even between medical centers in close proximity, perhaps affected by factors influencing local epidemiology including prior antifungal exposure and patient age within the ICU.67”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [67]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent exposure to an echinocandin was found to significantly increase the risk of infection with C. parapsilosis [85].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [85]
In the citing paper
“Often, for naturally susceptible species, both the relative amount of resistant strains and the overall MIC levels in clinical isolates increase after the continuous use of a given antifungal drug [44].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [44]
In the citing paper
“Quite soon after the introduction of the echinocandins it was noted that the increasing use was accompanied by epidemiological shifts with a proportional or numeric increase in the less susceptible C. parapsilosis at several centres (8;17;18).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
In the citing paper
“A consequence of enhanced drug exposure is increased selection pressure for resistance and indeed an altered species distribution for invasive infections has been linked to the echinocandin use (8).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 4×
“ysis of susceptibility profiles can occur (30).”
BackgroundResultInfluentialInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“The 2009 updated guidelines of the Infectious Diseases Society of America (IDSA) recommend that an echinocandin or fluconazole be used as first-line therapy for candidemia before identification of the causative species in nonneutropenic patients (27) and that an echinocandin be used in the case of exposure to fluconaz…”
BackgroundPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“caspofungin or fluconazole, the two major drugs recommended for the first-line treatment of candidemia and for preemptive/ prophylactic treatment in high-risk patients, was associated with changes in the epidemiology of the infection (22, 28).”
BackgroundPosaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · cited 1×
“In addition, they have been associated with reduced survival in cancer patients with recent azole administration (17, 38, 45).”
BackgroundWingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 2×
“krusei) to fluconazole is observed in hematology populations receiving prolonged fluconazole prophylactically (24, 46) as well as in ICU populations (6, 33).”
BackgroundCandida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“The relationship between the increased incidence of these species and fluconazole prescription has been debated ever since the introduction of fluconazole as prophylaxis in hematology wards (1, 15, 33, 46) and in ICUs (14).”
Background
Research works printed but not linked: 1
- Timsit, J., H. Dupont, J. Stahl, A. Tabah, O. Lortholary, C. Martin, A. Francais, B. Guidet, and E. Azoulay. 2009. Use of anitfungal therapy in ICU: a prevalent cohort study in 169 ICUs, abstr. M-1033/523. Abstr. 49th Intersci. Conf. Antimicrob. Chemother. American Society for Microbiology, Washington, DC.
Cited by
Items 101–200 of 402
Sampaio, P., & Pais, C. (2014) · Current Clinical Microbiology Reports · doi:10.1007/s40588-014-0002-y · Cited by 62
Mariette, C., Tavernier, E., Hocquet, D., Huynh, A., Isnard, F., Legrand, F., Lhéritier, V., Raffoux, E., Dombret, H., Ifrah, N., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1204652 · Cited by 62
Papp, C., Kocsis, K., Tóth, R., Bodai, L., Willis, J. R., Ksiezopolska, E., Lozoya-Pérez, N. E., Vágvölgyi, C., Mora Montes, H., Gabaldón, T., et al. (2018) · mSphere · doi:10.1128/msphere.00547-18 · Cited by 50
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
Won, E. J., Choi, M. J., Kim, M., Yong, D., Lee, W. G., Uh, Y., Kim, T. S., Byeon, S. A., Lee, S. Y., Kim, S. H., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.203482 · Cited by 59
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Ruhnke, M., Paiva, J. A., Meersseman, W., Pachl, J., Grigoras, I., Sganga, G., Menichetti, F., Montravers, P., Auzinger, G., Dimopoulos, G., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03784.x · Cited by 58
Mamali, V., Siopi, M., Charpantidis, S., Samonis, G., Tsakris, A., Vrioni, G., & on behalf of the Candi-Candi Network (2022) · Journal of Fungi · doi:10.3390/jof8020116 · Cited by 57
The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Schwartz, I. S., & Patterson, T. F. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0608-y · Cited by 57
Gomes, M. Z. R., Mulanovich, V. E., Jiang, Y., Lewis, R. E., & Kontoyiannis, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-13 · Cited by 56
Rosa, F. G. D., Corcione, S., Filippini, C., Raviolo, S., Fossati, L., Montrucchio, C., Aldieri, C., Petrolo, A., Cavallo, R., & Perri, G. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125149 · Cited by 56
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Pitarch, A., Nombela, C., & Gil, C. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025093146 · Cited by 56
The Hidden Pathogenic Potential of Environmental Fungi
Araújo, G. R. D. S., de Souza, W., & Frasés, S. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0124 · Cited by 54
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 46
Candida Infections: Clinical Features, Diagnosis and Treatment
Tamo, S. P. B. (2020) · Infectious Diseases and Clinical Microbiology · doi:10.36519/idcm.2020.0006 · Cited by 53
The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel
Israel, S., Amit, S., Israel, A., Livneh, A., Nir‐Paz, R., & Korem, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00352 · Cited by 51
Dudiuk, C., Gamarra, S., Leonardeli, F., Jimenez-Ortigosa, C., Vitale, R. G., Afeltra, J., Perlin, D. S., & Garcia-Effron, G. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01038-14 · Cited by 50
Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade
Parmeland, L., Gazon, M., Guerin, C., Argaud, L., Lehot, J.-J., Bastien, O., Allaouchiche, B., Michallet, M., Picot, S., Bienvenu, A.-L., et al. (2013) · Medical Mycology · doi:10.3109/13693786.2012.686673 · Cited by 45
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 50
Breakthrough candidaemia in the era of broad-spectrum antifungal therapies
Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49
Marcos-Zambrano, L. J., Escribano, P., Sánchez, C., Muñoz, P., Bouza, E., & Guinea, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02670-14 · Cited by 49
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
Blanchard, E., Lortholary, O., Boukris-Sitbon, K., Desnos-Ollivier, M., Dromer, F., Guillemot, D., & the French Mycosis Study Group (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00690-11 · Cited by 48
Self-citationCharsizadeh, A., Mirhendi, H., Nikmanesh, B., Eshaghi, H., & Makimura, K. (2018) · Mycoses · doi:10.1111/myc.12698 · Cited by 42
The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009
Oeser, C., Lamagni, T., Heath, P. T., Sharland, M., & Ladhani, S. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318275612e · Cited by 42
Risk factors for candidaemia: A prospective multi‐centre case‐control study
Keighley, C., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., Hajkowicz, K. M., Halliday, C. L., Kennedy, K., Kidd, S. E., et al. (2020) · Mycoses · doi:10.1111/myc.13211 · Cited by 48
How to Identify Invasive Candidemia in ICU—A Narrative Review
Alves, J., Alonso-Tarrés, C., & Rello, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121804 · Cited by 49
Govender, N. P., Avenant, T., Brink, A. J., Chibabhai, V., Cleghorn, J., du Toit, B., Govind, C., Lewis, E., Lowman, W., Mahlangu, H., et al. (2019) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v34i1.163 · Cited by 46
Secular trends of candidemia at a Brazilian tertiary care teaching hospital
Braga, P. R., Cruz, I. L., Ortiz, I., Barreiros, G., Nouér, S. A., & Nucci, M. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.07.008 · Cited by 46
Quindós, G., Miranda-Cadena, K., San-Millán, R., Borroto–Esoda, K., Cantón, E., Linares-Sicilia, M. J., Hamprecht, A. G., Montesinos, I., Tortorano, A. M., Prigitano, A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.906563 · Cited by 46
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study
Jacobs, D. M., Dilworth, T. J., Beyda, N. D., Casapao, A. M., & Bowers, D. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-17 · Cited by 45
Dawoud, A. M., Saied, S. A., Torayah, M. M., Ramadan, A. E., & Elaskary, S. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-61813-w · Cited by 44
Emerging drugs for the treatment of sepsis
Kotsaki, A., & Giamarellos‐Bourboulis, E. J. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.697151 · Cited by 44
López-Cortés, L. E., Almirante, B., Cuenca‐Estrella, M., Garnacho‐Montero, J., Padilla, B., Puig‐Asensio, M., Ruíz-Camps, I., Rodríguez‐Baño, J., Padilla, B., Muñóz, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.008 · Cited by 45
Sasso, M., Roger, C., Sasso, M., Poujol, H., Barbar, S. D., Lefrant, J., & Lachaud, L. (2017) · Mycoses · doi:10.1111/myc.12661 · Cited by 43
Corzo-León, D., Matute, T. A., Colombo, A. L., Cornejo‐Juárez, P., Cortés, J. A., Echevarria, J. I., Guzmán-Blanco, M., Macías, A. E., Nucci, M., Ostrosky-Zeichner, L. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097325 · Cited by 42
Desnos-Ollivier, M., Robert, V., Raoux-Barbot, D., Groenewald, M., & Dromer, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032278 · Cited by 37
Self-citationChen, J., Jiang, Y., Wei, B., Ding, Y., Xu, S., Qin, P., & Fu, J. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2042-9 · Cited by 41
Outbreak-Causing Fungi: Pneumocystis jirovecii
Dellière, S., Gits‐Muselli, M., Bretagne, S., & Alanio, A. (2019) · Mycopathologia · doi:10.1007/s11046-019-00408-w · Cited by 41
Self-citationAntifungal stewardship: developments in the field
Urbancic, K. F., Thursky, K., Kong, D. C. M., Johnson, P. D. R., & Slavin, M. A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000497 · Cited by 41
Al‐Rawahi, G. N., & Roscoe, D. L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/929717 · Cited by 41
Identification of Ebsulfur Analogues with Broad‐Spectrum Antifungal Activity
Ngo, H. X., Shrestha, S. K., & Garneau‐Tsodikova, S. (2016) · ChemMedChem · doi:10.1002/cmdc.201600236 · Cited by 38
Oliveira, V. K. P., Ruiz, L. D. S., Oliveira, N. A. D. J., Moreira, D. A., Hahn, R. C., Melo, A. S. D. A., Nishikaku, A. S., & Paula, C. R. (2014) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652014000400006 · Cited by 40
Won, E. J., Shin, J. H., Choi, M. J., Lee, W. G., Park, Y.-J., Uh, Y., Kim, S.-Y., Lee, M.-K., Kim, S. H., Shin, M. G., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118770 · Cited by 36
Reda, N. M., Hassan, R. M., Salem, S. T., & Yousef, R. (2022) · Infection · doi:10.1007/s15010-022-01888-7 · Cited by 40
Galia, L., Pezzani, M. D., Compri, M., Callegari, A., Rajendran, N. B., Carrara, E., Tacconelli, E., & the COMBACTE MAGNET EPI-Net Network (2022) · Journal of Fungi · doi:10.3390/jof8030249 · Cited by 38
Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment.
Desnos-Ollivier, M., Moquet, O., Chouaki, T., Guérin, A.-M., & Dromer, F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00325-11 · Cited by 37
Self-citationRisk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study
Schuster, M. G., Meibohm, A. R., Lloyd, L., & Strom, B. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.11.002 · Cited by 37
Kakeya, H., Yamada, K., Kaneko, Y., Yanagihara, K., Tateda, K., Maesaki, S., Takesue, Y., Tomono, K., Kadota, J.-I., Kaku, M., et al. (2018) · Medical Mycology Journal · doi:10.3314/mmj.17-00014 · Cited by 36
Treatment of invasive candidiasis in the era of Candida resistance
Paiva, J.-A., & Pereira, J. M. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001077 · Cited by 35
Invasive Candidiasis: Epidemiology and Risk Factors
Cortés, J. A., & Corrales, I. F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81813 · Cited by 34
Fungal Infections in Burn Patients
Palackic, A., Popp, D., Tapking, C., Houschyar, K. S., & Branski, L. K. (2020) · Surgical Infections · doi:10.1089/sur.2020.299 · Cited by 33
Epidemiology of Echinocandin Resistance in Candida
Grossman, N. T., Chiller, T. M., & Lockhart, S. R. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0209-7 · Cited by 28
Goemaere, B., Lagrou, K., Spriet, I., Hendrickx, M., & Becker, P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00591-18 · Cited by 32
Tiraboschi, I. N., Pozzi, N. C., Farías, L., García, S., & Fernández, N. (2017) · Revista chilena de infectología · doi:10.4067/s0716-10182017000500431 · Cited by 32
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 31
Caspofungin: a review of its characteristics, activity, and use in intensive care units
Hashemian, S. M. R., Farhadi, T., & Velayati, A. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1794817 · Cited by 31
Vannini, M., Emery, S., Lieutier-Colas, F., Legueult, K., Mondain, V., Retur, N., Gastaud, L., Pomares-Estran, C., & Hasseine, L. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101210 · Cited by 31
Recent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 32
Dupont, H., Guilbart, M., Ntouba, A., Perquin, M., Petiot, S., Regimbeau, J., Chouaki, T., Mahjoub, Y., & Zogheib, E. H. (2015) · Critical Care · doi:10.1186/s13054-015-0790-3 · Cited by 31
Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity
Duncan, V., Smith, D., Simpson, L., Lovie, E., Katvars, L., Berge, L., Robertson, J., Smith, S., Munro, C. A., Mercer, D., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02345-20 · Cited by 31
Hon, K. E., Chan, V. P. Y., Leung, A. K. C., Leung, K. K. Y., & Hui, W. F. (2024) · Drugs in Context · doi:10.7573/dic.2023-9-2 · Cited by 30
Echinocandin Failure Case Due to a Previously Unreported FKS1 Mutation in Candida krusei
Jensen, R. H., Justesen, U. S., Rewes, A., Perlin, D. S., & Arendrup, M. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02367-14 · Cited by 28
Drug-mediated metabolic tipping between antibiotic resistant states in a mixed-species community
Beardmore, R., Cook, E., Nilsson, S., Smith, A. R., Tillmann, A., Esquivel, B. D., Haynes, K., Gow, N. A. R., Brown, A. J. P., White, T. C., et al. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0582-7 · Cited by 30
Bourgeois, N., Laurens, C., Bertout, S., Balard, Y., Krasteva, D., Rispail, P., & Lachaud, L. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2069-z · Cited by 28
Effects of fluconazole on the metabolomic profile of Candida albicans
Katragkou, A., Alexander, E. L., Eoh, H., Raheem, S., Roilides, E., & Walsh, T. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv381 · Cited by 27
Candidaemia in a paediatric centre and importance of central venous catheter removal
Öncel, E. K., Kara, A., Özsürekçi, Y., Arıkan-Akdağlı, S., Cengiz, A. B., Ceyhan, M., Gür, D., Çelik, M., & Parlakay, A. Ö. (2015) · Mycoses · doi:10.1111/myc.12288 · Cited by 26
Bordallo-Cardona, M. Á., Marcos-Zambrano, L. J., Sánchez‐Carrillo, C., de la Pedrosa, E. G. G., Cantón, R., Bouza, E., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01982-17 · Cited by 26
Palmason, S., Marty, F. M., & Treister, N. S. (2011) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2011.07.012 · Cited by 26
Poissy, J., Rouzé, A., Cornu, M., Nseir, S., & Sendid, B. (2022) · Journal of Fungi · doi:10.3390/jof8090946 · Cited by 26
Optimizing the Treatment of Invasive Candidiasis—A Case for Combination Therapy
Wake, R. M., Allebone-Salt, P. E., John, L. L. H., Caswall, B. A., Govender, N. P., Ben‐Ami, R., Murray, L., Logan, C., Harrison, T. S., & Bicanic, T. A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae072 · Cited by 25
Jaffal, K., Poissy, J., Rouzé, A., Préau, S., Sendid, B., Cornu, M., & Nseir, S. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0392-8 · Cited by 25
Won, E. J., Choi, M. J., Jeong, S. H., Kim, D., Shin, K. S., Shin, J. H., Kim, Y. R., Kim, H. S., Kim, Y. A., Uh, Y., et al. (2022) · Journal of Fungi · doi:10.3390/jof8100996 · Cited by 24
Maldonado, N. A., Cano, L. E., de BEDOUT, C., Arbeláez, C. A. R., Roncancio, G. E., Tabares, A., Robledo, C. G., & Robledo, J. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.02.003 · Cited by 24
Lee, W., Hsu, J., Lai, M., Chiang, M., Lin, H.-C., Huang, H., Wu, I.-H., Chu, S., Fu, R.-H., & Tsai, M.-H. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2018.05.015 · Cited by 23
Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi
Khalifa, H. O., Oreiby, A. F., Abdelhamid, M. A. A., Ki, M., & Pack, S. P. (2024) · Biomimetics · doi:10.3390/biomimetics9070425 · Cited by 24
CAND-LO 2014–15 study: changing epidemiology of candidemia in Lombardy (Italy)
Prigitano, A., Cavanna, C., Passera, M., Ossi, C. M., Sala, E., Lombardi, G., Grancini, A., Luca, C. D., Bramati, S., Gelmi, M., et al. (2016) · Infection · doi:10.1007/s15010-016-0951-6 · Cited by 23
Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains
Denardi, L. B., Keller, J. T., Oliveira, V., Mario, D. A. N., Santúrio, J. M., & Alves, S. H. (2017) · Mycopathologia · doi:10.1007/s11046-017-0141-9 · Cited by 23
Huggins, J., Hohmann, S. F., & David, M. Z. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa628 · Cited by 23
Ferreira, D., Grenouillet, F., Blasco, G., Samain, E., Hénon, T., Dussaucy, A., Millon, L., Mercier, M., & Pili‐Floury, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3791-4 · Cited by 23
Liu, Z., Yang, H., Huang, R., Li, X., Sun, T., & Zhu, L. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00284-24 · Cited by 23
Microorganisms as biocontrol agents for sustainable agriculture
Koul, B., Chopra, M., & Lamba, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89938-3.00003-7 · Cited by 22
Francesco, M. A. D., Piccinelli, G., Gelmi, M. L., Gargiulo, F., Ravizzola, G., Pinsi, G., Peroni, L., Bonfanti, C., & Caruso, A. (2017) · Mycopathologia · doi:10.1007/s11046-017-0155-3 · Cited by 22
Martín-Gutiérrez, G., Peñalva, G., de Pipaón, M. R.-P., Aguilar, M., Gil-Navarro, M. V., Perez-Blanco, J.-L., Pérez-Moreno, M. A., Amaya‐Villar, R., Ferrándiz‐Millón, C., Gascón, M. L., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.01.002 · Cited by 22
Current insights into severe sepsis in cancer patients
Staudinger, T., & Pène, F. (2014) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20140051 · Cited by 22
Glöckner, A., & Cornely, O. A. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02208.x · Cited by 21
Timsit, J., Azoulay, É., Cornet, M., Gangneux, J., Jullien, V., Vesin, A., Schir, É., & Wolff, M. (2013) · Trials · doi:10.1186/1745-6215-14-399 · Cited by 21
Assembly and Antifungal Effect of a New Fluconazole-Carrier Nanosystem
de Lima, T. M., Arias, L. S., Afanaci, L. F., Rf, B. F., Neto, F. N. D. S., de Lima, B. H. R., Straioto, F. G., Camargo, E. R., Pessan, J. P., & Monteiro, D. R. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0182 · Cited by 21
Cytotoxic and Antifungal Amides Derived from Ferulic Acid: Molecular Docking and Mechanism of Action
de Morais, M. C., Pérez‐Castillo, Y., Silva, V. R., Santos, L. D. S., Soares, M. B. P., Bezerra, D. P., de Castro, R. D., & de Sousa, D. P. (2021) · BioMed Research International · doi:10.1155/2021/3598000 · Cited by 21
Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico
Pemán, J., & Zaragoza, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.002 · Cited by 21
Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 22
Guidelines for Antibiotics Prescription in Critically Ill Patients
Chaudhry, D., Desai, M., Gupta, M., Mohan, A., Mehta, Y. B., Sengar, M., Govil, D., Hegde, A. V., Rungta, N., Mittal, S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24677 · Cited by 20
Crea, F., Codda, G., Orsi, A., Battaglini, A., Giacobbe, D. R., Delfino, E., Ungaro, R., & Marchese, A. E. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.37.1900549 · Cited by 20
Olaechea‐Astigarraga, P., Álvarez-Lerma, F., Palomar, M., Ordeñana, J. I., López-Pueyo, M. J., Seijas, I., Otal-Entraigas, J. J., Gimeno-Costa, R., & Gracia, M. P. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.006 · Cited by 20
Orasch, C., Mertz, D., Garbino, J., van Delden, C., Emonet, S., Schrenzel, J., Zimmerli, S., Damonti, L., Mühlethaler, K., Imhof, A., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2017.12.018 · Cited by 19
Epidémiologie des candidoses invasives
Toubas, D. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71944-0 · Cited by 19
Bailly, S., Gautier‐Veyret, E., Lê, M., Bouadma, L., Andremont, O., Neuville, M., Mourvillier, B., Sonneville, R., Magalhaes, É., Lebut, J., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01545-20 · Cited by 19
Candidemia in the patient with malignancy
Alves, J., Palma, P., Azevedo, D., & Rello, J. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1508290 · Cited by 19
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 19
Self-citationChoice and duration of antifungal prophylaxis and treatment in high-risk haematology patients
Coussement, J., Lindsay, J., Teh, B. W., & Slavin, M. A. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000737 · Cited by 18
Chen, X., Shen, M., Feng, Q., Yang, G., Tian, R., Yao, S., & Zha, H. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11021-2 · Cited by 17
Metadata
- Authors
- Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris
- Centre National de la Recherche Scientifique (FR)
- Institut Pasteur (FR)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-02
- Volume
- 55
- Issue
- 2
- Pages
- 532-538
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3028765
- OpenAlex
- W1981025594
- Cited by
- 362
- References
- 47
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 18 · 2021: 18 · 2020: 31 · 2019: 16 · 2018: 34 · 2017: 30 · 2016: 23 · 2015: 31 · 2014: 41 · 2013: 24 · 2012: 26
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Pfizer
- Gilead Sciences
- Astellas Pharma
- Institut Gustave-Roussy
- Institut de Veille Sanitaire
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, caspofungin, fluconazole, Candida species distribution, Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, antifungal susceptibility, reduced susceptibility, fungemia, epidemiology
- MeSH terms
- Caspofungin, Adult, Antifungal Agents, Candida, Candida albicans, Child, Child, Preschool, Cross Infection, France, Humans, Microbial Sensitivity Tests, Paris, Population Surveillance, Prospective Studies, Species Specificity, Fluconazole, Prevalence, Drug Resistance, Fungal, Echinocandins, Lipopeptides, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.